Novartis' CEO warned Tuesday that U.S. drug pricing policy under President Donald Trump poses a "very difficult situation." ...

Novartis CEO Vas Narasimhan says that Europe needs a “complete rethink” on how it prices its drugs, warning that the entrance ...

We just covered the 14 Best Low Risk High Growth Stocks to Buy Right Now and AstraZeneca PLC (NYSE:AZN) ranks 5th on this ...

Continuous pen testing has replaced static annual tests and is reshaping how Evinova, a technology company of AstraZeneca, is ...

Vanguard Renewables today announced the completion of three renewable natural gas (RNG) facilities, marking a significant ...

FRANKFURT () - AstraZeneca's CEO told daily Handelsblatt on Tuesday that Germany risks missing out on new drugs that ‌the ...

Speaking to German newspaper Handelsblatt, CEO Pascal Soriot said proposed cost-cutting measures in the country’s healthcare ...

AstraZeneca PLC has announced that Rene Haas will step down as a Non-Executive Director on April 30, 2026. Haas has been appointed as the Chief Executive Officer of SoftBank Group International. This ...

By Maggie Fick and Bhanvi Satija BARCELONA, April 23 (Reuters) - Europe risks falling further behind the United States and ...

Today, Paradigm Health announced the launch of a landmark research collaboration with the U.S. Food & Drug Administration (FDA) focused on advancing a new model to accelerate clinical trial execution ...

Novartis (NVS) stock dropped 2% as Q1 sales missed estimates at $13.11B. Entresto plunged 42% on generics while CEO warns of ...